Literature DB >> 11306750

Cytologic and histologic correlation of atypical glandular cells of undetermined significance.

S Y Ha1, H I Cho, Y H Oh, J M Lee, K S Suh.   

Abstract

To determine the cytologic and histologic correlation of atypical glandular cells of undetermined significance (AGUS) in Papanicolaou smears, a cytology file from January 1998 to May 1999 was reviewed. Surgical pathology files were searched to determine which patients received subsequent biopsies. One hundred thirty-two patients with AGUS were identified. Corresponding biopsies were available for 82 of these cases. AGUS has been sub-classified into 3 subtypes: 1) AGUS, favor reactive; 2) AGUS, not otherwise specified; and 3) AGUS, favor neoplasia. The pathologic findings for the respective Papanicolaou smears with the diagnosis of each subtype of AGUS through the follow-up period were as follows: benign lesions in 56.1%, 0%, and 1.2%; squamous intraepithelial lesions 2.4%, 0%, and 1.2%; glandular intraepithelial lesions 0%, 0%, and 17.1%; endometrial simple hyperplasia 1.2%, 0%, and 0%; and carcinoma 0%, 9.8%, and 11%, respectively. In conclusion, AGUS, on cervical cytologic screening, was correlated with significant pathologic findings in 41.5% of the patients (37.8% with preinvasive or invasive glandular lesions and 9.6% with combined squamous intraepithelial lesions). It is thought that intensive follow-up studies, including colposcopy, cervical biopsy, and curettage, should be recommended for complete evaluation of AGUS.

Entities:  

Mesh:

Year:  2001        PMID: 11306750      PMCID: PMC3054719          DOI: 10.3346/jkms.2001.16.2.214

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  2 in total

1.  Atypical glandular cells in cervical smear during pregnancy and postpartum period.

Authors:  Kar Fai Tam
Journal:  Clin Med Res       Date:  2005-02

2.  More focus on atypical glandular cells in cervical screening: Risk of significant abnormalities and low histological follow-up rate.

Authors:  Pingping Zhong; Chenghong Yin; Yulan Jin; Tianbao Chen; Yang Zhan; Cheng Tian; Li Zhu; Xingzheng Zheng
Journal:  Cytojournal       Date:  2020-10-06       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.